Requirements for Haemopoietic Cellular Therapy
The Commission is revising the Requirements for procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cells. The updated standard will be renamed the Requirements for Haemopoietic Cellular Therapy (seventh edition) (the HCT Standard).
The survey and call for written submissions close on 12 August 2026. We are hosting online focus groups on 18 and 20 August 2026.
The revised HCT Standard has been developed to:
- reflect emerging technologies
- align with international FACT–JACIE requirements
- reduce duplication with existing Australian requirements.
The HCT Standard applies to services involved in donor selection, collection, processing, storage, issue or disposal of cellular therapy products, including haemopoietic progenitor cells and related products.
Your feedback will help ensure the HCT Standard is clear, practical and supports safety and quality across the sector.
Download the draft HCT Standard
Have your say
The Commission is seeking feedback through the following channels.
Online survey
The Commission invites members of the workforce and organisations to complete an online sector survey, and consumers to complete an online consumer survey to share their views on the draft Standard. Prior to completing the consumer survey, consumers can access the explanatory HCT consumer guide that gives an overview of the HCT Standard and how it supports high-quality HCT for consumers.
The consultation closes on Wednesday, 12 August 2026.
Written submissions
Individuals and organisations may provide feedback to our Pathology Standards team by email.
The submission can address all or any of the consultation questions outlined in the written submission questions document.
Written submissions close on Wednesday, 12 August 2026.
Online focus groups
Stakeholders can also participate in an online focus group to discuss the draft HCT Standard.
Online focus groups will be held on 18 August and 20 August.
Outcome of the consultation
Following the consultation, the Commission will:
- analyse the feedback with the National Pathology Accreditation Advisory Council and the Human Haemopoietic Progenitor Cells Working Group
- finalise the Requirements for Cellular Therapy (seventh edition) for release in 2027.
Keep up to date
Subscribe to our mailing list for updates on the Commission’s work on pathology.